INDIAN CLONES OF VIAGRA TO HIT MARKET SOON

Article Abstract:

Indian pharmaceutical companies are developing a cheaper version of the Viagra pill for treating male impotence. This has forced Pfizer Inc of US, the producer of the pill, to postpone its plans to launch Viagra in the domestic market. Pfizer's market share may be eroded if Indian firms export sildenafil citrate, an active ingredient of Viagra in bulk. Orchid Chemicals and Pharmaceuticals Ltd, Chennai, has developed an alternative process to produce sildenafil citrate. It plans to export 40 tonnes of sildenafil citrate. Cipla, Ranbaxy Laboratories and Dr Reddy's Laboratories have applied to the Drug Controller of India for permission to introduce sildenafil citrate. (khr) >EN

Comment:

India: Pharmaceutical companies are developing a cheaper version of the Viagra pill for treating male impotence

Prostate Disorder Preparations, Prostate agents, Article

---

ALEMBIC TO MANUFACTURE CEPH-C GROUP OF BULK DRUGS

Article Abstract:

Alembic Chemical Works Ltd of Baroda plans to manufacture cephalosporin-C (Ceph-C) group of bulk drugs. The company's Ceph- C facility is to have a capacity of 100 tonnes. It plans to use its existing bulk drug manufacturing facility at Baroda to produce Ceph-C. It will be one of the only companies to produce Ceph-C on a large scale. (khr)

United States, Pharmaceutical preparations, Cephalosporin Preparations, Cephalosporins, Alembic Chemical Works Ltd

---

POTATO MAY SOON REPLACE PILL FOR CURING CHOLERA

Article Abstract:

The All India Institute of Medical Sciences says that the country can benefit from developing genetically engineered plants that can not only provide better quality nutrition but also produce antibodies, vaccines and hormones. Potatoes may soon replace pills for curing cholera and tobacco may combat tuberculosis. (khr)

Comment:

The All India Institute of Medical Sciences says that the country can benefit from developing genetically engineered plants that can not only provide better quality nutrition but also produce antibodies, vaccines and hormones.

Research and Development in the Physical, Engineering, and Life Sciences, Science & research, Research and Testing Services, Plant Genetics, Medical Research, Biological products exc. diagnostic, Vaccines for Human Use, Antibodies for Human Use, Vaccines, Antibodies

Similar abstracts:

• Abstracts: SAMSUNG LAUNCHES NEW IT PRODUCTS. ACC TO ENHANCE PRESENCE WITH THREE NEW BRANDS. LEGO TO BUILD UP PRESENCE IN SOUTH
• Abstracts: A CHEMISTRY THAT WORKS: HOECHST MARION ROUSSEL INFAR TO INVEST Rs100 Cr, PLANS MANUFACTURING UNIT. PRICE HIKE WILL BENEFIT ONLY DR REDDY's
• Abstracts: INDIAN BLUECHIPS TARGET MAURITIUS TO SET UP BASE. BNP TO SOON SET UP BANKING OUTFIT
• Abstracts: SUNIL AGRO FOODS LIMITED HLL TARGETS Rs700 CR TURNOVER IN POPULAR FOODS NESTLE INDIA LIMITED

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.